Xoma | XOMA - Attività





Attività Cambiamento Data
AbbVie USD 133.96B 62M 2025-12
Agenus USD 226.8M 7.09M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Ardelyx USD 501.6M 15.43M 2025-12
aTyr Pharma USD 515.34M 408.68M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Celldex Therapeutics USD 582.98M 65.46M 2025-12
Curis USD 29.23M 10.09M 2025-06
Eli Lilly USD 112.48B 2.46B 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Incyte USD 6.96B 627.62M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Prothena USD 326.8M 25.82M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Xoma USD 263.15M 39.7M 2025-09